This Biotech's Stock Could Double If Its Treatment for Major Depressive Disorder Succeeds, Says Mizuho
This Biotech's Stock Could Double If Its Treatment for Major Depressive Disorder Succeeds, Says Mizuho
瑞穗證券表示，如果該生物技術公司的治療嚴重抑鬱症的藥物成功，其股票可能翻倍。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間